Monday, Apr 29, 1996
South San Francisco, Calif. -- April 29, 1996 --Genentech, Inc. (NYSE: GNE) today announced the appointment of Dennis Henner as Vice President of Research and a member of its Operations Committee. The post, previously headed by Genentech President and CEO Arthur Levinson, oversees what many see as the most prolific research organization in the biotechnology industry. Henner had been serving as Acting Vice President of Research since Levinson's appointment as president and CEO.
"Dennis Henner has been instrumental in leading the strategic direction and scientific productivity at Genentech," said Arthur Levinson. "Dennis has strong qualifications in terms of scientific credentials, management capability, and understanding of our research culture and our scientific staff," added Levinson.
Henner joined Genentech in 1981 as a scientist in the Molecular Biology department after completing his Ph.D. in Microbiology at the University of Virginia Medical School and his postdoctoral fellowship at Scripps Clinic & Research Foundation. He was promoted to Director of Cell Genetics in 1986, became a Staff Scientist in 1990, and was appointed Vice President of Research Technology in 1994. He has published more than 60 papers in peer-reviewed scientific journals or books.
Genentech is a leading biotechnology company that discovers, develops, manufactures and markets human pharmaceuticals for significant unmet medical needs. Ten of the currently marketed biotechnology products stem from Genentech research, five of which Genentech markets directly. The company has headquarters in South San Francisco, California, and is traded on the New York and Pacific Stock Exchanges under the symbol GNE. Genentech's world wide web address is http://www.gene.com.
# # #